Long-term analysis of cellular immunity in patients with RRMM treated with CAR-T cell therapy-Reference-Cited by-同舟云学术

Long-term analysis of cellular immunity in patients with RRMM treated with CAR-T cell therapy

Published:2023-10-31 Issue:8 Volume:23 Page:5241-5254
ISSN:1591-9528
Container-title:Clinical and Experimental Medicine
language:en
Short-container-title:Clin Exp Med

Author:

Cheng Hai,Ji Shengwei,Wang Jiaojiao,Hua Tian,Chen Zihan,Liu Jiaying,Shao Lingyan,Wang Xue,Chen Wei,Sang Wei,Qi Kunming,Li Zhenyu,Sun Cai,Shi Ming,Qiao Jianlin,Wu Qingyun,Zeng Lingyu,Fei Xiaoming,Huang Hongming,Gu Weiying,Xu Kailin,Zheng Junnian,Cao Jiang

Funder

the Key Research & Development Plan of Jiangsu Province

Xuzhou Medical leading talents Training program

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10238-023-01232-9.pdf

Reference48 articles.

1. Raje N, Berdeja J, Lin Y, et al. Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma. N Engl J Med. 2019;380:1726–37. https://doi.org/10.1056/NEJMoa1817226.

2. Brudno JN, Maric I, Hartman SD, et al. T cells genetically modified to express an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of poor-prognosis relapsed multiple myeloma. J Clin Oncol. 2018;36:2267–80. https://doi.org/10.1200/JCO.2018.77.8084.

3. Ali SA, Shi V, Maric I, et al. T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma. Blood. 2016;128(13):1688–700. https://doi.org/10.1182/blood-2016-04-711903.

4. Garfall AL, Maus MV, Hwang WT, et al. Chimeric antigen receptor T cells against CD19 for multiple myeloma. N Engl J Med. 2015;373:1040–7. https://doi.org/10.1056/NEJMoa1504542.

5. Wang Y, Cao J, Gu W, et al. Long-term follow-up of combination of B-cell maturation antigen and CD19 chimeric antigen receptor T cells in multiple myeloma. J Clin Oncol. 2022;40:2246–56. https://doi.org/10.1200/JCO.21.01676.